+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
Cancer Immunotherapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Immunotherapy - Global Strategic Business Report

  • Report
  • November 2024
  • 93 Pages
  • Global
From
Somatostatin Analogs - Global Strategic Business Report - Product Thumbnail Image

Somatostatin Analogs - Global Strategic Business Report

  • Report
  • November 2024
  • 94 Pages
  • Global
From
From
From
From
Urothelial Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Urothelial Cancer Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 93 Pages
  • Global
From
Doxorubicin - Global Strategic Business Report - Product Thumbnail Image

Doxorubicin - Global Strategic Business Report

  • Report
  • November 2024
  • 288 Pages
  • Global
From
Antineoplastic Agents - Global Strategic Business Report - Product Thumbnail Image

Antineoplastic Agents - Global Strategic Business Report

  • Report
  • November 2024
  • 93 Pages
  • Global
From
From
From
Basal Cell Carcinoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Basal Cell Carcinoma Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 173 Pages
  • Global
From
From
Tumor Ablation Technologies - Global Strategic Business Report - Product Thumbnail Image

Tumor Ablation Technologies - Global Strategic Business Report

  • Report
  • November 2024
  • 196 Pages
  • Global
From
CAR T-cell Therapy - Global Strategic Business Report - Product Thumbnail Image

CAR T-cell Therapy - Global Strategic Business Report

  • Report
  • November 2024
  • 179 Pages
  • Global
From
Ovarian Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Ovarian Cancer Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 118 Pages
  • Global
From
Immunotherapy Drugs - Global Strategic Business Report - Product Thumbnail Image

Immunotherapy Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
Ablation Technologies - Global Strategic Business Report - Product Thumbnail Image

Ablation Technologies - Global Strategic Business Report

  • Report
  • November 2024
  • 436 Pages
  • Global
From
From
Kidney Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Kidney Cancer Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 148 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more